ARTICLE | Clinical News
Positron Emission Mammography diagnostic data
November 21, 2011 8:00 AM UTC
A Korean trial analyzing 113 breast lesions from 101 patients with a mean tumor size of 2.2 cm showing that Naviscan's PEM with fluorodeoxyglucose had a significantly higher sensitivity for tumor dete...